On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...